公开(公告)号：US09776990B2

公开(公告)日：2017-10-03

申请号：US13796731

申请日：2013-03-12

Applicant: AbbVie Inc.

Inventor： John K Pratt ,  Dachun Liu ,  Chang H Park ,  George S Sheppard ,  Lisa A Hasvold ,  Le Wang

IPC: A61K31/4035 ,  A61K31/404 ,  C07D209/44 ,  C07D209/48 ,  C07D409/12 ,  C07D403/10 ,  C07D405/12 ,  A61K31/5377 ,  A61K45/06 ,  C07D405/04 ,  C07D403/04 ,  A61K31/4184 ,  C07D405/10 ,  C07D401/12 ,  A61K31/4439 ,  A61K31/4709 ,  C07D403/12 ,  A61K31/416 ,  C07D417/12 ,  A61K31/427 ,  C07D401/10 ,  C07D409/10

CPC classification number: C07D409/12 ,  A61K31/4035 ,  A61K31/404 ,  A61K31/416 ,  A61K31/4184 ,  A61K31/427 ,  A61K31/4439 ,  A61K31/4709 ,  A61K31/5377 ,  A61K45/06 ,  C07D209/44 ,  C07D209/48 ,  C07D401/10 ,  C07D401/12 ,  C07D403/04 ,  C07D403/10 ,  C07D403/12 ,  C07D405/04 ,  C07D405/10 ,  C07D405/12 ,  C07D409/10 ,  C07D417/12

Abstract: The present invention provides for compounds of formula (I) wherein A, Y, J, R1, R2, and R3 have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, diabetes, obesity, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula I.